APA

Macdonald S. J. F., Dowle M. D., Harrison L. A., Clarke G. D. E., Inglis G. G. A., Johnson M. R., Shah P., Smith R. A., Amour A., Fleetwood G., Humphreys D. C., Molloy C. R., Dixon M., Godward R. E., Wonacott A. J., Singh O. M. P., Hodgson S. T. & Hardy G. W. (20020923). Discovery of further pyrrolidine trans-lactams as inhibitors of human neutrophil elastase (HNE) with potential as development candidates and the crystal structure of HNE complexed with an inhibitor (GW475151). : Journal of medicinal chemistry.

Chicago

Macdonald Simon J F, Dowle Michael D, Harrison Lee A, Clarke Geoffrey D E, Inglis Graham G A, Johnson Martin R, Shah Pritom, Smith Robin A, Amour Augustin, Fleetwood Gill, Humphreys Davina C, Molloy Christopher R, Dixon Mary, Godward Rosalind E, Wonacott Alan J, Singh Onkar M P, Hodgson Simon T and Hardy George W. 20020923. Discovery of further pyrrolidine trans-lactams as inhibitors of human neutrophil elastase (HNE) with potential as development candidates and the crystal structure of HNE complexed with an inhibitor (GW475151). : Journal of medicinal chemistry.

Harvard

Macdonald S. J. F., Dowle M. D., Harrison L. A., Clarke G. D. E., Inglis G. G. A., Johnson M. R., Shah P., Smith R. A., Amour A., Fleetwood G., Humphreys D. C., Molloy C. R., Dixon M., Godward R. E., Wonacott A. J., Singh O. M. P., Hodgson S. T. and Hardy G. W. (20020923). Discovery of further pyrrolidine trans-lactams as inhibitors of human neutrophil elastase (HNE) with potential as development candidates and the crystal structure of HNE complexed with an inhibitor (GW475151). : Journal of medicinal chemistry.

MLA

Macdonald Simon J F, Dowle Michael D, Harrison Lee A, Clarke Geoffrey D E, Inglis Graham G A, Johnson Martin R, Shah Pritom, Smith Robin A, Amour Augustin, Fleetwood Gill, Humphreys Davina C, Molloy Christopher R, Dixon Mary, Godward Rosalind E, Wonacott Alan J, Singh Onkar M P, Hodgson Simon T and Hardy George W. Discovery of further pyrrolidine trans-lactams as inhibitors of human neutrophil elastase (HNE) with potential as development candidates and the crystal structure of HNE complexed with an inhibitor (GW475151). : Journal of medicinal chemistry. 20020923.